Functional dyspepsia

Therapeutic Advances in Gastroenterology

Volumn 3, Issue 3, 2010, Pages 145-164

  Brun, Rita ^a   Kuo, Braden ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Drug therapy; Functional dyspepsia; Gastric motility; Visceral hypersensitivity

Indexed keywords

ANTACID AGENT; BISMUTH; CISAPRIDE; DOMPERIDONE; FAMOTIDINE; HISTAMINE H2 RECEPTOR ANTAGONIST; IBEROGAST; ITOPRIDE; LANSOPRAZOLE; METOCLOPRAMIDE; MISOPROSTOL; NITRIC OXIDE; OMEPRAZOLE; PAROXETINE; PEPPERMINT OIL; PIRENZEPINE; PLACEBO; PLANT EXTRACT; PROKINETIC AGENT; PROTON PUMP INHIBITOR; RANITIDINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; SILDENAFIL; SUCRALFATE; SUMATRIPTAN; TANDOSPIRONE; TEGASEROD; TRICYCLIC ANTIDEPRESSANT AGENT; UNCLASSIFIED DRUG; UNINDEXED DRUG;

CLINICAL PRACTICE; CLINICAL TRIAL; DRUG DOSE COMPARISON; DYSPEPSIA; EPIGASTRIC PAIN; FUNCTIONAL DYSPEPSIA; GASTROINTESTINAL SYMPTOM; HEART ARRHYTHMIA; HUMAN; PATHOGENESIS; PATHOPHYSIOLOGY; POSTPRANDIAL DISTRESS SYNDROME; PREVALENCE; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; STOMACH EMPTYING;

EID: 77953387875     PISSN: 1756283X     EISSN: None     Source Type: Journal    
DOI: 10.1177/1756283X10362639     Document Type: Review

References (131)

1. Agreus, L. and Borgquist, L. ( 2002) The cost of gastro-oesophageal reflux disease, dyspepsia and peptic ulcer disease in Sweden. Pharmaco Economics 20: 347-355.
2. Archimandritis, A., Tzivras, M., Fertakis, A., Emmanuel, A., Laoudi, F., Kalantzis, N. et al. (1992) Cisapride, metoclopramide, and ranitidine in the treatment of severe nonulcer dyspepsia. Clin Ther 14: 553-561.
3. Aro, P., Talley, N.J., Ronkainen, J., Storskrubb, T., Vieth, M., Johansson, S.E. et al. (2009) Anxiety is associated with uninvestigated and functional dyspepsia (Rome III criteria) in a Swedish population-based study. Gastroenterology 137: 94-100.
4. Baron, J.H., Watson, F. and Sonnenberg, A. ( 2006) Three centuries of stomach symptoms in Scotland. Aliment Pharmacol Ther 24: 821-829.
5. Barton, P.M., Moayyedi, P., Talley, N.J., Vakil, N.B. and Delaney, B.C. ( 2008) A second-order simulation model of the cost-effectiveness of managing dyspepsia in the United States. Med Decis Making 28: 44-55.
6. Bernersen, B., Johnsen, R. and Straume, B. ( 1996) Non-ulcer dyspepsia and peptic ulcer: the distribution in a population and their relation to risk factors. Gut 38: 822-825.
7. Boeckxstaens, G.E., Hirsch, D.P., Kuiken, S.D., Heisterkamp, S.H. and Tytgat, G.N. ( 2002) The proximal stomach and postprandial symptoms in functional dyspeptics. Am J Gastroenterol 97: 40-48.
8. Boeckxstaens, G.E., Hirsch, D.P., van Den Elzen, B.D., Heisterkamp, S.H. and Tytgat, G.N. ( 2001) Impaired drinking capacity in patients with functional dyspepsia: relationship with proximal stomach function. Gastroenterology 121: 1054-1063.
9. Boehme, M.W., Autschbach, F., Ell, C. and Raeth, U. ( 2007) Prevalence of silent gastric ulcer, erosions or severe acute gastritis in patients with type 2 diabetes mellitus - a cross-sectional study. Hepatogastroenterology 54: 643-648.
10. Bouras, E.P., Delgado-Aros, S., Camilleri, M., Castillo, E.J., Burton, D.D., Thomforde, G.M. et al. (2002) SPECT imaging of the stomach: comparison with barostat, and effects of sex, age, body mass index, and fundoplication. Single Photon Emission Computed Tomography. Gut 51: 781-786.
11. Bouras, E.P., Talley, N.J., Camilleri, M., Burton, D.D., Heckman, M.G., Crook, J.E. et al. (2008) Effects of amitriptyline on gastric sensorimotor function and postprandial symptoms in healthy individuals: a randomized, double-blind, placebo-controlled trial. Am J Gastroenterol 103: 2043-2050.
12. Bredenoord, A.J., Chial, H.J., Camilleri, M., Mullan, B.P. and Murray, J.A. ( 2003) Gastric accommodation and emptying in evaluation of patients with upper gastrointestinal symptoms. Clin Gastroenterol Hepatol 1: 264-272.
13. Calvert, E.L., Houghton, L.A., Cooper, P., Morris, J. and Whorwell, P.J. ( 2002) Long-term improvement in functional dyspepsia using hypnotherapy. Gastroenterology 123: 1778-1785.
14. Camilleri, M. and Zinsmeister, A.R. ( 2009) Candidate genes and functional dyspepsia. Neurogastroenterol Motil 21: 94.
15. Carvalho, R.V., Lorena, S.L., de Souza, Almeida J.R. and Mesquita, M.A. (2009) Food intolerance, diet composition, and eating patterns in functional dyspepsia patients. Dig Dis Sci 55 (1): 60-65.
16. Chen, T.S., Luo, J.C. and Chang, F.Y. (2009) Psychosocial-spiritual factors in patients with functional dyspepsia: a comparative study with normal individuals having the same endoscopic features. Eur J Gastroenterol Hepatol 22 (1): 75-80.
17. Choung, R.S., Locke, G.R., Schleck, C.D., Zinsmeister, A.R. and Talley, N.J. ( 2007) Do distinct dyspepsia subgroups exist in the community? A population-based study. Am J Gastroenterol 102: 1983-1989.
18. Collen, M.J. and Loebenberg, M.J. ( 1989) Basal gastric acid secretion in nonulcer dyspepsia with or without duodenitis. Dig Dis Sci 34: 246-250.
19. Corsetti, M., Caenepeel, P., Fischler, B., Janssens, J. and Tack, J. ( 2004) Impact of coexisting irritable bowel syndrome on symptoms and pathophysiological mechanisms in functional dyspepsia. Am J Gastroenterol 99: 1152-1159.
20. Cremonini, F., Locke 3rd, G.R., Schleck, C.D., Zinsmeister, A.R. and Talley, N.J. ( 2006) Relationship between upper gastrointestinal symptoms and changes in body weight in a population-based cohort. Neurogastroenterol Motil 18: 987-994.
21. de Maeyer, J.H., Lefebvre, R.A. and Schuurkes, J.A. ( 2008) 5-HT4 receptor agonists: similar but not the same. Neurogastroenterol Motil 20: 99-112.
22. de Schepper, H.U., Cremonini, F., Chitkara, D. and Camilleri, M. ( 2004) Assessment of gastric accommodation: overview and evaluation of current methods. Neurogastroenterol Motil 16: 275-285.
23. de Smet, B., Mitselos, A. and Depoortere, I. (2009) Motilin and ghrelin as prokinetic drug targets. Pharmacol Ther 123: 207-223.
24. Delaney, B., Ford, A.C., Forman, D., Moayyedi, P. and Qume, M. ( 2005) Initial management strategies for dyspepsia. Cochrane Database Syst Rev: CD001961.
25. Delaney, B.C., Moayyedi, P. and Forman, D. ( 2003) Initial management strategies for dyspepsia. Cochrane Database Syst Rev: CD001961.
26. Delgado-Aros, S., Camilleri, M., Cremonini, F., Ferber, I., Stephens, D. and Burton, D.D. ( 2004a) Contributions of gastric volumes and gastric emptying to meal size and postmeal symptoms in functional dyspepsia. Gastroenterology 127: 1685-1694.
27. Delgado-Aros, S., Locke 3rd, G.R., Camilleri, M., Talley, N.J., Fett, S., Zinsmeister, A.R. et al. (2004 b) Obesity is associated with increased risk of gastrointestinal symptoms: a population-based study. Am J Gastroenterol 99: 1801-1806.
28. Distrutti, E., Azpiroz, F., Soldevilla, A. and Malagelada, J.R. ( 1999) Gastric wall tension determines perception of gastric distention. Gastroenterology 116: 1035-1042.
29. Elfvin, A., Andersson, S., Abrahamsson, H., Edebo, A., Simren, M. and Lonroth, H. ( 2007) Percutaneous implantation of gastric electrodes - a novel technique applied in animals and in patients. Neurogastroenterol Motil 19: 103-109.
30. Ford, A.C., Marwaha, A., Lim, A. and Moayyedi, P. ( 2009) Systematic review and meta-analysis of the prevalence of irritable bowel syndrome in individuals with dyspepsia. Clin Gastroenterol Hepatol. Jul 23 [Epub ahead of print].
31. Fumagalli, I. and Hammer, B. ( 1994) Cisapride versus metoclopramide in the treatment of functional dyspepsia. A double-blind comparative trial. Scand J Gastroenterol 29: 33-37.
32. Gathaiya, N., Locke III, G.R., Camilleri, M., Schleck, C.D., Zinsmeister, A.R. and Talley, N.J. ( 2009) Novel associations with dyspepsia: a community-based study of familial aggregation, sleep dysfunction and somatization. Neurogastroenterol Motil 21 (9): 922-e69.
33. Geeraerts, B., van Oudenhove, L., Fischler, B., Vandenberghe, J., Caenepeel, P., Janssens, J. et al. (2009) Influence of abuse history on gastric sensorimotor function in functional dyspepsia. Neurogastroenterol Motil 21: 33-41.
34. Gerson, L.B., Shetler, K. and Triadafilopoulos, G. ( 2002) Prevalence of Barrett's esophagus in asymptomatic individuals. Gastroenterology 123: 461-467.
35. Ghoos, Y.F., Maes, B.D., Geypens, B.J., Mys, G., Hiele, M.I., Rutgeerts, P.J. et al. (1993) Measurement of gastric emptying rate of solids by means of a carbon-labeled octanoic acid breath test. Gastroenterology 104: 1640-1647.
36. Haag, S., Talley, N.J. and Holtmann, G. ( 2004) Symptom patterns in functional dyspepsia and irritable bowel syndrome: relationship to disturbances in gastric emptying and response to a nutrient challenge in consulters and non-consulters. Gut 53: 1445-1451.
37. Halder, S.L., Locke 3rd, G.R., Schleck, C.D., Zinsmeister, A.R., Melton III, L.J. and Talley, N.J. ( 2007) Natural history of functional gastrointestinal disorders: a 12-year longitudinal population-based study. Gastroenterology 133: 799-807.
38. Halling, K., Kulich, K., Carlsson, J. and Wiklund, I. ( 2008) An international comparison of the burden of illness in patients with dyspepsia. Dig Dis 26: 264-273.
39. Halter, F., Staub, P., Hammer, B., Guyot, J. and Miazza, B.M. ( 1997) Study with two prokinetics in functional dyspepsia and GORD: domperidone vs. cisapride. J Physiol Pharmacol 48: 185-192.
40. Hamilton, J., Guthrie, E., Creed, F., Thompson, D., Tomenson, B., Bennett, R. et al. (2000) A randomized controlled trial of psychotherapy in patients with chronic functional dyspepsia. Gastroenterology 119: 661-669.
41. Hanevik, K., Dizdar, V., Langeland, N. and Hausken, T. (2009) Development of functional gastrointestinal disorders after Giardia lamblia infection. BMC Gastroenterol 9: 27.
42. Hare, E. ( 1991) The history of ‘nervous disorders’ from 1600 to 1840, and a comparison with modern views. Br J Psychiatry 159: 37-45.
43. Hiyama, T., Yoshihara, M., Matsuo, K., Kusunoki, H., Kamada, T., Ito, M. et al. (2007) Meta-analysis of the effects of prokinetic agents in patients with functional dyspepsia. J Gastroenterol Hepatol 22: 304-310.
44. Hjelland, I.E., Svebak, S., Berstad, A., Flatabo, G. and Hausken, T. ( 2007) Breathing exercises with vagal biofeedback may benefit patients with functional dyspepsia. Scand J Gastroenterol 42: 1054-1062.
45. Hojo, M., Miwa, H., Yokoyama, T., Ohkusa, T., Nagahara, A., Kawabe, M. et al. (2005) Treatment of functional dyspepsia with antianxiety or antidepressive agents: systematic review. J Gastroenterol 40: 1036-1042.
46. Holtmann, G., Adam, B., Haag, S., Collet, W., Grunewald, E. and Windeck, T. ( 2003a) Efficacy of artichoke leaf extract in the treatment of patients with functional dyspepsia: a six-week placebo-controlled, double-blind, multicentre trial. Aliment Pharmacol Ther 18: 1099-1105.
47. Holtmann, G., Haag, S., Adam, B., Funk, P., Wieland, V. and Heydenreich, C.J. ( 2003b) Effects of a fixed combination of peppermint oil and caraway oil on symptoms and quality of life in patients suffering from functional dyspepsia. Phytomedicine 10(Suppl 4): 56-57.
48. Holtmann, G., Talley, N.J., Liebregts, T., Adam, B. and Parow, C. ( 2006) A placebo-controlled trial of itopride in functional dyspepsia. N Engl J Med 354: 832-840.
49. Hradsky, M. and Wikander, M. ( 1982) Effect of pirenzepine in the treatment of non-ulcer dyspepsia. A double-blind study. Scand J Gastroenterol Suppl 72: 251-254.
50. Jackson, J.L., O'Malley, P.G., Tomkins, G., Balden, E., Santoro, J. and Kroenke, K. ( 2000) Treatment of functional gastrointestinal disorders with antidepressant medications: a meta-analysis. Am J Med 108: 65-72.
51. Jankowski, J.A. and Talley, N.J. ( 2009) Dissecting GI phenotype-genotype relationships in GERD and dyspepsia: an SNP here and an SNP there! Am J Gastroenterol 104: 286-288.
52. Jeong, J.J., Choi, M.G., Cho, Y.S., Lee, S.G., Oh, J.H., Park, J.M. et al. (2008) Chronic gastrointestinal symptoms and quality of life in the Korean population. World J Gastroenterol 14: 6388-6394.
53. Jones, M. and Talley, N.J. (2009) Minimum clinically important difference for the Nepean Dyspepsia Index, a validated quality of life scale for functional dyspepsia. Am J Gastroenterol 104: 1483-1488.
54. Jones, M.P., Talley, N.J., Eslick, G.D., Dubois, D. and Tack, J. ( 2008) Community subgroups in dyspepsia and their association with weight loss. Am J Gastroenterol 103: 2051-2060.
55. Jones, R.H. ( 2002) Approaches to uninvestigated dyspepsia. Gut 50(Suppl 4): iv42-iv46.
56. Keohane, J. and Quigley, E.M. ( 2007) Functional dyspepsia and nonerosive reflux disease: clinical interactions and their implications. Med Gen Med 9: 31.
57. Kim, D.Y., Delgado-Aros, S., Camilleri, M., Samsom, M., Murray, J.A., O'Connor, M.K. et al. (2001) Noninvasive measurement of gastric accommodation in patients with idiopathic nonulcer dyspepsia. Am J Gastroenterol 96: 3099-3105.
58. Kindt, S., Dubois, D., van Oudenhove, L., Caenepeel, P., Arts, J., Bisschops, R. et al. (2009 a) Relationship between symptom pattern, assessed by the PAGI-SYM(C) questionnaire, and gastric sensorimotor dysfunction in functional dyspepsia. Neurogastroenterol Motil 21 (11): 1183-e105.
59. Kindt, S., Tertychnyy, A., de Hertogh, G., Geboes, K. and Tack, J. (2009 b) Intestinal immune activation in presumed post-infectious functional dyspepsia. Neurogastroenterol Motil 21: e832-e856.
60. Kindt, S., van Oudenhove, L., Broekaert, D., Kasran, A., Ceuppens, J.L., Bossuyt, X. et al. (2009 c) Immune dysfunction in patients with functional gastrointestinal disorders. Neurogastroenterol Motil 21: 389-398.
61. Koloski, N.A., Talley, N.J. and Boyce, P.M. ( 2003) Does psychological distress modulate functional gastrointestinal symptoms and health care seeking? A prospective, community Cohort study. Am J Gastroenterol 98: 789-797.
62. Ladabaum, U. and Glidden, D. ( 2002) Effect of the selective serotonin reuptake inhibitor sertraline on gastric sensitivity and compliance in healthy humans. Neurogastroenterol Motil 14: 395-402.
63. Lankarani, K.B., Moghadami, M., Masoumpoor, M., Geramizadeh, B. and Omrani, G.R. ( 2004) Serum leptin level in patients with functional dyspepsia. Dig Liver Dis 36: 717-721.
64. Lee, K.J., Cha, D.Y., Cheon, S.J., Yeo, M. and Cho, S.W. (2009) Plasma ghrelin levels and their relationship with gastric emptying in patients with dysmotility-like functional dyspepsia. Digestion 80: 58-63.
65. Liu, S., Peng, S., Hou, X., Ke, M. and Chen, J.D. ( 2008) Transcutaneous electroacupuncture improves dyspeptic symptoms and increases high frequency heart rate variability in patients with functional dyspepsia. Neurogastroenterol Motil 20: 1204-1211.
66. Lix, L.M., Graff, L.A., Walker, J.R., Clara, I., Rawsthorne, P., Rogala, L. et al. (2008) Longitudinal study of quality of life and psychological functioning for active, fluctuating, and inactive disease patterns in inflammatory bowel disease. Inflamm Bowel Dis 14: 1575-1584.
67. Matsumoto, Y., Ito, M., Tsuge, M., Matsuo, T., Tanaka, S., Haruma, K. et al. (2009) Ecabet sodium induces neuronal nitric oxide synthase-derived nitric oxide synthesis and gastric adaptive relaxation in the human stomach. J Gastroenterol 44 (11): 1118-1124.
68. May, B., Kohler, S. and Schneider, B. ( 2000) Efficacy and tolerability of a fixed combination of peppermint oil and caraway oil in patients suffering from functional dyspepsia. Aliment Pharmacol Ther 14: 1671-1677.
69. Mearin, F., Cucala, M., Azpiroz, F. and Malagelada, J.R. ( 1991) The origin of symptoms on the brain-gut axis in functional dyspepsia. Gastroenterology 101: 999-1006.
70. Mearin, F., Pérez-Oliveras, M., Perelló, A., Vinyet, J., Ibañez, A., Coderch, J. et al. (2005) Dyspepsia and irritable bowel syndrome after a S. gastroenteritis outbreak: one-year follow-up cohort study. Gastroenterology 129: 98-104.
71. Miwa, H., Nagahara, A., Tominaga, K., Yokoyama, T., Sawada, Y., Inoue, K. et al. (2009) Efficacy of the 5-HT1A agonist tandospirone citrate in improving symptoms of patients with functional dyspepsia: a randomized controlled trial. Am J Gastroenterol 104: 2779-2787.
72. Moayyedi, P., Deeks, J., Talley, N.J., Delaney, B. and Forman, D. ( 2003a) An update of the Cochrane Systematic Review of Helicobacter pylori eradication therapy in nonulcer dyspepsia: resolving the discrepancy between systematic reviews. Am J Gastroenterol 98: 2621-2626.
73. Moayyedi, P., Soo, S., Deeks, J., Delaney, B., Innes, M. and Forman, D. ( 2006) Pharmacological interventions for non-ulcer dyspepsia. Cochrane Database Syst Rev: CD001960.
74. Moayyedi, P., Soo, S., Deeks, J., Forman, D., Harris, A., Innes, M. et al. (2003 b) Systematic review: antacids, H2-receptor antagonists, prokinetics, bismuth and sucralfate therapy for non-ulcer dyspepsia. Aliment Pharmacol Ther 17: 1215-1227.
75. O'Morain, C. ( 2006) Role of Helicobacter pylori in functional dyspepsia. World J Gastroenterol 12: 2677-2680.
76. Orihata, M. and Sarna, S.K. ( 1994) Contractile mechanisms of action of gastroprokinetic agents: cisapride, metoclopramide, and domperidone. Am J Physiol 266: G665-G676.
77. Pfaffenbach, B., Adamek, R.J., Bartholomaus, C. and Wegener, M. ( 1997) Gastric dysrhythmias and delayed gastric emptying in patients with functional dyspepsia. Dig Dis Sci 42: 2094-2099.
78. Piessevaux, H., de Winter, B., Louis, E., Muls, V., de Looze, D., Pelckmans, P. et al. (2009) Dyspeptic symptoms in the general population: a factor and cluster analysis of symptom groupings. Neurogastroenterol Motil 21: 378-388.
79. Pilichiewicz, A.N., Feltrin, K.L., Horowitz, M., Holtmann, G., Wishart, J.M., Jones, K.L. et al. (2008) Functional dyspepsia is associated with a greater symptomatic response to fat but not carbohydrate, increased fasting and postprandial CCK, and diminished PYY. Am J Gastroenterol 103: 2613-2623.
80. Pilichiewicz, A.N., Horowitz, M., Holtmann, G.J., Talley, N.J. and Feinle-Bisset, C. (2009) Relationship between symptoms and dietary patterns in patients with functional dyspepsia. Clin Gastroenterol Hepatol 7: 317-322.
81. Pilichiewicz, A.N., Horowitz, M., Russo, A., Maddox, A.F., Jones, K.L., Schemann, M. et al. (2007) Effects of Iberogast on proximal gastric volume, antropyloroduodenal motility and gastric emptying in healthy men. Am J Gastroenterol 102: 1276-1283.
82. Qin, F., Huang, X. and Ren, P. (2009) Chinese herbal medicine modified xiaoyao san for functional dyspepsia: meta-analysis of randomized controlled trials. J Gastroenterol Hepatol 24: 1320-1325.
83. Quigley, E.M. and Keohane, J. ( 2008) Dyspepsia. Curr Opin Gastroenterol 24: 692-697.
84. Rabeneck, L., Cook, K.F., Wristers, K., Souchek, J., Menke, T. and Wray, N.P. ( 2001) SODA (Severity of Dyspepsia Assessment): a new effective outcome measure for dyspepsia-related health. J Clin Epidemiol 54: 755-765.
85. Rentz, A.M., Kahrilas, P., Stanghellini, V., Tack, J., Talley, N.J., de La Loge, C. et al. (2004) Development and psychometric evaluation of the patient assessment of upper gastrointestinal symptom severity index (PAGI-SYM) in patients with upper gastrointestinal disorders. Qual Life Res 13: 1737-1749.
86. Rhee, P.L., Kim, Y.H., Son, H.J., Kim, J.J., Koh, K.C., Paik, S.W. et al. (1999) Lack of association of Helicobacter pylori infection with gastric hypersensitivity or delayed gastric emptying in functional dyspepsia. Am J Gastroenterol 94: 3165-3169.
87. Rosch, W., Liebregts, T., Gundermann, K.J., Vinson, B. and Holtmann, G. ( 2006) Phyto therapy for functional dyspepsia: a review of the clinical evidence for the herbal preparation STW 5. Phytomedicine 13(Suppl 5): 114-121.
88. Sandler, R.S., Everhart, J.E., Donowitz, M., Adams, E., Cronin, K., Goodman, C. et al. (2002) The burden of selected digestive diseases in the United States. Gastroenterology 122: 1500-1511.
89. Sarnelli, G., Caenepeel, P., Geypens, B., Janssens, J. and Tack, J. ( 2003a) Symptoms associated with impaired gastric emptying of solids and liquids in functional dyspepsia. Am J Gastroenterol 98: 783-788.
90. Sarnelli, G., Cuomo, R., Janssens, J. and Tack, J. ( 2003b) Symptom patterns and pathophysiological mechanisms in dyspeptic patients with and without Helicobacter pylori. Dig Dis Sci 48: 2229-2236.
91. Sarnelli, G., Sifrim, D., Janssens, J. and Tack, J. ( 2004) Influence of sildenafil on gastric sensorimotor function in humans. Am J Physiol Gastrointest Liver Physiol 287: G988-G992.
92. Schiller, L.R. and Johnson, D.A. ( 2008) Balancing drug risk and benefit: toward refining the process of FDA decisions affecting patient care. Am J Gastroenterol 103: 815-819.
93. Sha, W., Pasricha, P.J. and Chen, J.D. (2009) Correlations among electrogastrogram, gastric dysmotility, and duodenal dysmotility in patients with functional dyspepsia. J Clin Gastroenterol 43 (8): 716-722.
94. Shaib, Y. and El-Serag, H.B. ( 2004) The prevalence and risk factors of functional dyspepsia in a multiethnic population in the United States. Am J Gastroenterol 99: 2210-2216.
95. Simren, M., Vos, R., Janssens, J. and Tack, J. ( 2003) Acid infusion enhances duodenal mechanosensitivity in healthy subjects. Am J Physiol Gastrointest Liver Physiol 285: G309-G315.
96. Soo, S., Moayyedi, P., Deeks, J., Delaney, B., Lewis, M. and Forman, D. ( 2005) Psychological interventions for non-ulcer dyspepsia. Cochrane Database Syst Rev: CD002301.
97. Sundberg, R., Palmqvist, M., Tunsater, A. and Toren, K. (2009) Health-related quality of life in young adults with asthma. Respir Med 103 (10): 1580-1585.
98. Suzuki, H., Inadomi, J.M. and Hibi, T. ( 2009) Japanese herbal medicine in functional gastrointestinal disorders. Neurogastroenterol Motil. Mar 25 [Epub ahead of print].
99. Tack, J., Broekaert, D., Coulie, B., Fischler, B. and Janssens, J. ( 2003a) Influence of the selective serotonin re-uptake inhibitor, paroxetine, on gastric sensorimotor function in humans. Aliment Pharmacol Ther 17: 603-608.
100. Tack, J., Caenepeel, P., Corsetti, M. and Janssens, J. ( 2004) Role of tension receptors in dyspeptic patients with hypersensitivity to gastric distention. Gastroenterology 127: 1058-1066.
101. Tack, J., Caenepeel, P., Fischler, B., Piessevaux, H. and Janssens, J. ( 2001) Symptoms associated with hypersensitivity to gastric distention in functional dyspepsia. Gastroenterology 121: 526-535.
102. Tack, J., Caenepeel, P., Piessevaux, H., Cuomo, R. and Janssens, J. ( 2003b) Assessment of meal induced gastric accommodation by a satiety drinking test in health and in severe functional dyspepsia. Gut 52: 1271-1277.
103. Tack, J., Coulie, B., Wilmer, A., Andrioli, A. and Janssens, J. ( 2000) Influence of sumatriptan on gastric fundus tone and on the perception of gastric distension in man. Gut 46: 468-473.
104. Tack, J., Muller-Lissner, S., Bytzer, P., Corinaldesi, R., Chang, L., Viegas, A. et al. (2005) A randomised controlled trial assessing the efficacy and safety of repeated Tegaserod therapy in women with irritable bowel syndrome with constipation. Gut 54: 1707-1713.
105. Tack, J., Piessevaux, H., Coulie, B., Caenepeel, P. and Janssens, J. ( 1998) Role of impaired gastric accommodation to a meal in functional dyspepsia. Gastroenterology 115: 1346-1352.
106. Tack, J., Vos, R., Janssens, J., Salter, J., Jauffret, S. and Vandeplassche, G. ( 2003c) Influence of Tegaserod on proximal gastric tone and on the perception of gastric distension. Aliment Pharmacol Ther 18: 1031-1037.
107. Takamori, K., Mizuta, Y., Takeshima, F., Akazawa, Y., Isomoto, H., Ohnita, K. et al. (2007) Relation among plasma ghrelin level, gastric emptying, and psycho-logic condition in patients with functional dyspepsia. J Clin Gastroenterol 41: 477-483.
108. Talley, N.J., Ruff, K., Jiang, X. and Jung, H.K. ( 2008a) The Rome III classification of dyspepsia: will it help research? Dig Dis 26: 203-209.
109. Talley, N.J., Stanghellini, V., Heading, R.C., Koch, K.L., Malagelada, J.R. and Tytgat, G.N. ( 1999) Functional gastroduodenal disorders. Gut 45(Suppl 2): 1137-1142.
110. Talley, N.J., Tack, J., Ptak, T., Gupta, R. and Giguere, M. ( 2008b) Itopride in functional dyspepsia: results of two phase III multicentre, randomised, double-blind, placebo-controlled trials. Gut 57: 740-746.
111. Talley, N.J. and Vakil, N. ( 2005) Guidelines for the management of dyspepsia. Am J Gastroenterol 100: 2324-2337.
112. Talley, N.J., Weaver, A.L. and Zinsmeister, A.R. ( 1995) Impact of functional dyspepsia on quality of life. Dig Dis Sci 40: 584-589.
113. Tatsuta, M. and Iishi, H. ( 1993) Effect of treatment with liu-jun-zi-tang (TJ-43) on gastric emptying and gastrointestinal symptoms in dyspeptic patients. Aliment Pharmacol Ther 7: 459-462.
114. Thumshirn, M., Bruninga, K. and Camilleri, M. ( 1997) Simplifying the evaluation of postprandial antral motor function in patients with suspected gastroparesis. Am J Gastroenterol 92: 1496-1500.
115. Troncon, L.E., Bennett, R.J., Ahluwalia, N.K. and Thompson, D.G. ( 1994) Abnormal intragastric distribution of food during gastric emptying in functional dyspepsia patients. Gut 35: 327-332.
116. Vakil, N., Laine, L., Talley, N.J., Zakko, S.F., Tack, J., Chey, W.D. et al. (2008) Tegaserod treatment for dysmotility-like functional dyspepsia: results of two randomized, controlled trials. Am J Gastroenterol 103: 1906-1919.
117. van Den Elzen, B.D., Bennink, R.J., Holman, R., Tytgat, G.N. and Boeckxstaens, G.E. ( 2007) Impaired drinking capacity in patients with functional dyspepsia: intragastric distribution and distal stomach volume. Neurogastroenterol Motil 19: 968-976.
118. van Kerkhoven, L.A., Laheij, R.J., Aparicio, N., de Boer, W.A., van den Hazel, S., Tan, A.C. et al. (2008) Effect of the antidepressant venlafaxine in functional dyspepsia: a randomized, double-blind, placebo-controlled trial. Clin Gastroenterol Hepatol 6: 746-752; quiz 718.
119. van Kerkhoven, L.A., van Rossum, L.G., van Oijen, M.G., Tan, A.C., Laheij, R.J. and Jansen, J.B. ( 2006) Upper gastrointestinal endoscopy does not reassure patients with functional dyspepsia. Endoscopy 38: 879-885.
120. van Lelyveld, N., Linde, J.T., Schipper, M. and Samsom, M. ( 2008) Candidate genotypes associated with functional dyspepsia. Neurogastroenterol Motil 20: 767-773.
121. van Oudenhove, L., Vandenberghe, J., Geeraerts, B., Vos, R., Persoons, P., Fischler, B. et al. (2008) Determinants of symptoms in functional dyspepsia: gastric sensorimotor function, psychosocial factors or somatisation? Gut 57: 1666-1673.
122. van Outryve, M., de Nutte, N., van Eeghem, P. and Gooris, J.P. ( 2003) Efficacy of cisapride in functional dyspepsia resistant to domperidone or metoclopramide: a double-blind, placebo-controlled study. Scand J Gastroenterol Suppl 195: 47-52.
123. Vandenberghe, J., Dupont, P., van Oudenhove, L., Bormans, G., Demyttenaere, K., Fischler, B. et al. (2007) Regional cerebral blood flow during gastric balloon distention in functional dyspepsia. Gastroenterology 132: 1684-1693.
124. Veldhuyzen van Zanten, S.J., Jones, M.J., Verlinden, M. and Talley, N.J. ( 2001) Efficacy of cisapride and domperidone in functional (nonulcer) dyspepsia: a meta-analysis. Am J Gastroenterol 96: 689-696.
125. von Arnim, U., Peitz, U., Vinson, B., Gundermann, K.J. and Malfertheiner, P. ( 2007) STW 5, a phytopharmacon for patients with functional dyspepsia: results of a multicenter, placebo-controlled double-blind study. Am J Gastroenterol 102: 1268-1275.
126. Welen, K., Faresjo, A. and Faresjo, T. ( 2008) Functional dyspepsia affects women more than men in daily life: a case-control study in primary care. Gend Med 5: 62-73.
127. Wiseman, L.R. and Faulds, D. ( 1994) Cisapride. An updated review of its pharmacology and therapeutic efficacy as a prokinetic agent in gastrointestinal motility disorders. Drugs 47: 116-152.
128. Wysowski, D.K. and Bacsanyi, J. ( 1996) Cisapride and fatal arrhythmia. N Engl J Med 335: 290-291.
129. Xu, S., Hou, X., Zha, H., Gao, Z., Zhang, Y. and Chen, J.D. ( 2006) Electroacupuncture accelerates solid gastric emptying and improves dyspeptic symptoms in patients with functional dyspepsia. Dig Dis Sci 51: 2154-2159.
130. Zai, H. and Kusano, M. (2009) Investigation of gastric emptying disorders in patients with functional dyspepsia reveals impaired inhibitory gastric emptying regulation in the early postcibal period. Digestion 79(Suppl 1): 13-18.
131. Zeng, F., Song, W.Z., Liu, X.G., Xie, H.J., Tang, Y., Shan, B.C. et al. (2009) Brain areas involved in acupuncture treatment on functional dyspepsia patients: a PET-CT study. Neurosci Lett 456: 6-10.